News
19h
GlobalData on MSNHansa’s Idefirix shows potential as pre-treatment to ElevidysHansa Biosciences’ Idefirix (imlifidase) has reduced patients’ antibodies to a level that allows dosing in patients with ...
SRPT's Q2 report, set to arrive Aug. 6, is likely to have Elevidys updates, restructuring plans and sales outlook in sharp investor focus.
After Loomer targeted surgeon general nominee and Kennedy ally Casey Means, Means’s brother, Calley, suggested that Loomer’s ...
Swedish biotech Hansa Biopharma on Friday released encouraging top-line results from three patients with Duchenne muscular ...
Bulwark reporter Will Sommer reports MAGA influencer Laura Loomer is drawing criticism from MAGA members who claim she’s ...
11h
Raw Story on MSN'A plant!' Far-right turns on MAGA mega influencer after major ousterA far-right influencer close to President Donald Trump faces suspicion from some of her fellow conspiracy theorists, who ...
The cost of high-end, breakthrough medications traumatizes patients and their families. According to USAfacts, “national ...
10h
Stockhead on MSNHealth Check: Audeara strives to be ‘the next Cochlear’ in affordable hearing collabHearing minnow Audeara has entered an alliance with Ear Science Institute Australia to develop an affordable bone conduction hearing device.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results